Your browser doesn't support javascript.
loading
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors.
Jeschke, Jana; Collignon, Evelyne; Al Wardi, Clémence; Krayem, Mohammad; Bizet, Martin; Jia, Yan; Garaud, Soizic; Wimana, Zéna; Calonne, Emilie; Hassabi, Bouchra; Morandini, Renato; Deplus, Rachel; Putmans, Pascale; Dube, Gaurav; Singh, Nitesh Kumar; Koch, Alexander; Shostak, Kateryna; Rizzotto, Lara; Ross, Robert L; Desmedt, Christine; Bareche, Yacine; Rothé, Françoise; Lehmann-Che, Jacqueline; Duterque-Coquillaud, Martine; Leroy, Xavier; Menschaert, Gerben; Teixeira, Luis; Guo, Mingzhou; Limbach, Patrick A; Close, Pierre; Chariot, Alain; Leucci, Eleonora; Ghanem, Ghanem; Yuan, Bi-Feng; Willard-Gallo, Karen; Sotiriou, Christos; Marine, Jean-Christophe; Fuks, François.
Afiliação
  • Jeschke J; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Collignon E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Al Wardi C; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Krayem M; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium.
  • Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Jia Y; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Garaud S; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Wimana Z; Molecular Immunology Laboratory, Institut Jules Bordet, ULB, Brussels, Belgium.
  • Calonne E; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium.
  • Hassabi B; Department of Nuclear Medicine, Institut Jules Bordet, ULB, Brussels, Belgium.
  • Morandini R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Deplus R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Putmans P; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium.
  • Dube G; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Singh NK; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Koch A; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Shostak K; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Rizzotto L; Department of Pathology, Maastricht UMC, Maastricht, the Netherlands.
  • Ross RL; Laboratory of Medical Chemistry, GIGA Stem Cells, University of Liège, Liège, Belgium.
  • Desmedt C; Trace, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
  • Bareche Y; Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA.
  • Rothé F; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium.
  • Lehmann-Che J; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium.
  • Duterque-Coquillaud M; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium.
  • Leroy X; Pathophysiology of Breast Cancer Team, Université de Paris, INSERM U976, HIPI, Paris, France.
  • Menschaert G; Breast Disease Unit and Molecular Oncology Unit, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Teixeira L; Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-UMR-S 1277, CANTHER, Lille, France.
  • Guo M; Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-UMR-S 1277, CANTHER, Lille, France.
  • Limbach PA; Department of Pathology, CHU Lille, Université Lille, Lille, France.
  • Close P; Biobix, Laboratory of Bioinformatics and Computational Genomics, Ghent University, Ghent, Belgium.
  • Chariot A; Pathophysiology of Breast Cancer Team, Université de Paris, INSERM U976, HIPI, Paris, France.
  • Leucci E; Breast Disease Unit and Molecular Oncology Unit, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Ghanem G; Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing, China.
  • Yuan BF; Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA.
  • Willard-Gallo K; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium.
  • Sotiriou C; WELBIO, University of Liège, Liège, Belgium.
  • Marine JC; Laboratory of Medical Chemistry, GIGA Stem Cells, University of Liège, Liège, Belgium.
  • Fuks F; WELBIO, University of Liège, Liège, Belgium.
Nat Cancer ; 2(6): 611-628, 2021 06.
Article em En | MEDLINE | ID: mdl-35121941
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA / Neoplasias Epiteliais e Glandulares Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA / Neoplasias Epiteliais e Glandulares Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica